After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, AGIO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Agios Pharmaceuticals Inc is $1.95B. A total of 0.54 million shares were traded on the day, compared to an average of 916.73K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, AGIO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Burns James William sold 4,005 shares of AGIO for 35.54 per share on Mar 03 ’25. After the transaction, the Chief Legal Officer now owns 18,650 company shares. In a previous transaction on Mar 03 ’25, Jones Cecilia sold 2,275 shares at 35.54 per share. AGIO shares that Chief Financial Officer owns now total 21,843.
Among the insiders who sold shares, Milanova Tsveta disposed of 1,681 shares on Mar 03 ’25 at a per-share price of $35.54. This resulted in the Chief Commercial Officer holding 22,892 shares of AGIO after the transaction. In another insider transaction, Goff Brian sold 12,947 shares at $35.54 per share on Mar 03 ’25. Company shares held by the Chief Executive Officer now total 83,139.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for AGIO in the last 3 months, the mean price target is $55.13 with high estimates of $74.00 and low estimates of $43.00. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $27.14.
As of this writing, AGIO has an earnings estimate of -$1.76 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$1.47 per share and a lower estimate of -$1.93.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $26.96, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.30.
